Keyphrases
Acute Myeloid Leukemia
100%
Flow Cytometric
100%
Mutational Profile
100%
FMS-like Tyrosine Kinase 3 (FLT3)
50%
ASXL1
50%
Therapy-related
50%
SNP Array
25%
Next-generation Sequencing
25%
Pathogenic mutations
25%
Aberrations
25%
CD34
25%
Retrospective Review
25%
Distinctive Features
25%
Leukemia
25%
Gene Fusion
25%
In(III)
25%
University of Washington
25%
St. Louis
25%
CD117
25%
University Medical Centre
25%
Chicago
25%
Cytogenetic Abnormalities
25%
Genomic Features
25%
Leukemic Blast
25%
Diagnostic Challenge
25%
Tyrosine Kinase Domain
25%
CD45
25%
Immunophenotyping
25%
Immunophenotypic Profile
25%
Memorials
25%
CD13
25%
CD33
25%
Tyrosine Kinase Domain mutations
25%
KAT6A
25%
High Side
25%
CD64
25%
Side Scatter
25%
7q Deletion
25%
Unique Morphology
25%
CREBBP Gene
25%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Receptor Tyrosine Kinase
40%
Tyrosine Kinase
40%
ASXL1
40%
Single-Nucleotide Polymorphism
20%
Next Generation Sequencing
20%
Gene Fusion
20%
Cytogenetics
20%
CD34
20%
Immunophenotyping
20%
CD33
20%
Alanine Aminopeptidase
20%
CD117
20%
Genomics
20%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Protein Tyrosine Kinase
50%
ASXL1
50%
Single Nucleotide Polymorphism
25%
Next Generation Sequencing
25%
Gene Fusion
25%
Leukemia
25%
Immunophenotyping
25%
Alanine Aminopeptidase
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Protein Tyrosine Kinase
50%
Leukemia
25%
Alanine Aminopeptidase
25%